Biotech leaps ahead in venture funding – report

SAN FRANCISCO, July 20 (Reuters) – Biotechnology leapt
ahead as the biggest recipient of U.S. venture capital money in
the second quarter, but first-time venture investments in
companies overall dropped to a 15-year low, a trade association
reported on Monday.

Leave a Reply